MEF2A overexpression inhibits RCC progression by inhibiting the Wnt/β‐catenin pathway, arresting G1/S1 transition of cell cycle, and inducing RCC cell apoptosis. The gene discussed is MEF2A; the disease is renal cell carcinoma.